Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hokusai VTE PEDIATRICS
NCT02798471Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2017
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 34
01
Overview
A Phase 3 trial of edoxaban in venous thromboembolism (VTE), sponsored by Daiichi Sankyo Co., Ltd.. Started Mar 2017; status: completed.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02798471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02798471.